Difference of Serum BDNF Levels Between Schizophrenic Patients with Smoking in Batak Male and Controls

Deasy Hendriati, E. Effendy, M. Amin
{"title":"Difference of Serum BDNF Levels Between Schizophrenic Patients with Smoking in Batak Male and Controls","authors":"Deasy Hendriati, E. Effendy, M. Amin","doi":"10.21276/IJLSSR.2018.4.1.12","DOIUrl":null,"url":null,"abstract":"Background: Schizophrenia is a severe psychiatric disorder, generally affects approximately 1% of the world population but the pathogenesis of schizophrenia is still unclear. Accumulating evidence shows that brain-derived neurotrophic factor (BDNF) may be involved in the pathophysiology of schizophrenia. Use of nicotine associated with upregulation of BDNF in the serum. Based on the higher smoking rates among schizophrenic patients and the close relationship between nicotine and BDNF, as well as the repeatedly found alternations of BDNF levels in schizophrenia, many studies have suggested that smoking could play a role in the altered BDNF levels of schizophrenic patients. Aims: To determine the difference of serum BDNF levels among schizophrenia and non schizophrenia smoking in Batak male. Methods: Serum BDNF levels were measured in 68 Batak males, who smoke (34 subjects with chronic schizophrenia, which was diagnosed with MINI-ICD X and 34 subjects non schizophrenia as controls), all subjects were aged 20-60 years old, did not suffer from other mental disorders, neurologic disease, and no history of alcohol and other substances except tobacco. Serum BDNF was analyzed with the Quantitative sandwich enzyme immunoassay technique by the use of Quantikine ELISA Human CXCL8/IL-8 HS (R&D Systems, Inc., Minneapolis, USA). Results: The serum BDNF levels were lower in the schizophrenic patients with smoking in Batak males than in the control subjects, reaching statistically (26.228±5.722.5 pg/ml) vs (33.148±7.290.4 pg/ml). Conclusion: There is a significant difference in serum BDNF levels between schizophrenic patients with smoking in Batak males and controls. Key-wordsSchizophrenia, Batak male, Smoking, Brain-derived Neurotrophic Factor INTRODUCTION Schizophrenia is a psychotic disorder that is generally characterized by distorted thinking and perception of the fundamental and distinctive, and therefore affects the unnatural (Inappropriate) or blunt (blunted). [1] Schizophrenia is a severe and chronic mental disorder with a high prevalence (about 1% of the general population), usually beginning before the age of 25, lasting throughout life, and of people from all social classes. [2] The etiology and pathophysiology of schizophrenia have not been explained so far. Various changes in the central nervous system can lead to clinical manifestations of the disease. Neurotropin plays an important role in regulating the development and maintenance of peripheral and central nervous system functions. Access this article online Quick Response Code Website:","PeriodicalId":22509,"journal":{"name":"The International Journal of Life-Sciences Scientific Research","volume":"58 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International Journal of Life-Sciences Scientific Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21276/IJLSSR.2018.4.1.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Schizophrenia is a severe psychiatric disorder, generally affects approximately 1% of the world population but the pathogenesis of schizophrenia is still unclear. Accumulating evidence shows that brain-derived neurotrophic factor (BDNF) may be involved in the pathophysiology of schizophrenia. Use of nicotine associated with upregulation of BDNF in the serum. Based on the higher smoking rates among schizophrenic patients and the close relationship between nicotine and BDNF, as well as the repeatedly found alternations of BDNF levels in schizophrenia, many studies have suggested that smoking could play a role in the altered BDNF levels of schizophrenic patients. Aims: To determine the difference of serum BDNF levels among schizophrenia and non schizophrenia smoking in Batak male. Methods: Serum BDNF levels were measured in 68 Batak males, who smoke (34 subjects with chronic schizophrenia, which was diagnosed with MINI-ICD X and 34 subjects non schizophrenia as controls), all subjects were aged 20-60 years old, did not suffer from other mental disorders, neurologic disease, and no history of alcohol and other substances except tobacco. Serum BDNF was analyzed with the Quantitative sandwich enzyme immunoassay technique by the use of Quantikine ELISA Human CXCL8/IL-8 HS (R&D Systems, Inc., Minneapolis, USA). Results: The serum BDNF levels were lower in the schizophrenic patients with smoking in Batak males than in the control subjects, reaching statistically (26.228±5.722.5 pg/ml) vs (33.148±7.290.4 pg/ml). Conclusion: There is a significant difference in serum BDNF levels between schizophrenic patients with smoking in Batak males and controls. Key-wordsSchizophrenia, Batak male, Smoking, Brain-derived Neurotrophic Factor INTRODUCTION Schizophrenia is a psychotic disorder that is generally characterized by distorted thinking and perception of the fundamental and distinctive, and therefore affects the unnatural (Inappropriate) or blunt (blunted). [1] Schizophrenia is a severe and chronic mental disorder with a high prevalence (about 1% of the general population), usually beginning before the age of 25, lasting throughout life, and of people from all social classes. [2] The etiology and pathophysiology of schizophrenia have not been explained so far. Various changes in the central nervous system can lead to clinical manifestations of the disease. Neurotropin plays an important role in regulating the development and maintenance of peripheral and central nervous system functions. Access this article online Quick Response Code Website:
巴塔克男性吸烟精神分裂症患者与对照组血清BDNF水平的差异
背景:精神分裂症是一种严重的精神障碍,通常影响约1%的世界人口,但精神分裂症的发病机制仍不清楚。越来越多的证据表明,脑源性神经营养因子(BDNF)可能参与精神分裂症的病理生理过程。使用尼古丁与血清中BDNF的上调有关。基于精神分裂症患者较高的吸烟率以及尼古丁与BDNF之间的密切关系,以及多次发现精神分裂症患者BDNF水平的改变,许多研究表明吸烟可能在精神分裂症患者BDNF水平的改变中起作用。目的:探讨巴塔克男性精神分裂症与非精神分裂症吸烟者血清BDNF水平的差异。方法:对68名Batak男性吸烟人群(34名慢性精神分裂症患者,诊断为MINI-ICD X, 34名非精神分裂症患者作为对照)进行血清BDNF水平检测,所有受试者年龄在20-60岁之间,无其他精神障碍和神经系统疾病,无酒精和除烟草以外的其他物质史。采用定量夹心酶免疫分析法,采用Quantikine ELISA Human CXCL8/IL-8 HS (R&D Systems, Inc., Minneapolis, USA)检测血清BDNF。结果:巴塔克男性吸烟精神分裂症患者血清BDNF水平低于对照组,分别为(26.228±5.722.5 pg/ml)和(33.148±7.290.4 pg/ml)。结论:巴塔克男性吸烟精神分裂症患者血清BDNF水平与对照组有显著差异。精神分裂症是一种精神障碍,通常以扭曲的思维和对基本和独特的感知为特征,因此影响不自然(不恰当)或钝(钝化)。[1]精神分裂症是一种严重的慢性精神障碍,发病率很高(约占总人口的1%),通常在25岁之前开始,持续一生,社会各阶层的人都有。[2]迄今为止,精神分裂症的病因和病理生理尚未得到解释。中枢神经系统的各种变化可导致该病的临床表现。神经妥乐平在调节周围和中枢神经系统功能的发育和维持中起重要作用。在线阅读本文快速响应代码网站:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信